Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

JOINTS Study - Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites (JOINTS)

9 de julho de 2007 atualizado por: MedStar National Rehabilitation Network

Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites

  1. What are the characteristics of joint replacement patients (DRGs 209 & 210) served in IRFs and SNFs? How are they similar or different?
  2. How are the interventions and processes of care for joint replacement patients different in IRFs and SNFs?
  3. What specific interventions or combinations of interventions in IRFs and SNFs make the biggest difference in outcomes for joint replacement patients taking into account patient differences?
  4. Which joint replacement patients do better in an IRF and which do better in a SNF?
  5. What is the relative cost-effectiveness of IRF and SNF care for joint replacement patients?
  6. Are comorbidities among joint replacement patients an adequate indicator of additional medical need during the rehabilitation process? Can a severity-of-illness measure serve as a better indicator of medical need? Are patients with greater medical needs served better in an IRF or a SNF?
  7. Can we design a more efficient course of rehabilitation interventions for joint replacement patients in IRFs and SNFs to reduce the length of stay and costs?

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

  1. What are the characteristics of joint replacement patients (DRGs 209 & 210) served in IRFs and SNFs? How are they similar or different?

    We need to know if there are systematic differences among joint replacement patients served in both settings and take these into account when evaluating outcomes and cost effectiveness as outlined below. See also Question 6.

  2. How are the interventions and processes of care for joint replacement patients different in IRFs and SNFs?

    How can we best characterize the differences in the care received in an IRF vs. a SNF? What makes the care in an IRF and a SNF different? What do they do similarly and what do they do differently? Consider all interventions, e.g., nursing services, physician interventions, physical and occupational therapies, nutritional support, medications, passive motion exercises, weight-bearing exercises. Also consider timing, intensity, frequency, and duration of therapies.

  3. What specific interventions or combinations of interventions in IRFs and SNFs make the biggest difference in outcomes for joint replacement patients taking into account patient differences?

    The relevant outcomes for this study include: (1) the onset of complications during the course of treatment, (2) change in severity of illness from admission to discharge, (3) discharge destination (including unscheduled discharges to acute care), and (4) change in functional status from admission to discharge. We will consider (5) rehospitalizations or readmissions in the first 3-6 months following discharge from post-acute care.

  4. Which joint replacement patients do better in an IRF and which do better in a SNF?

    How can we best characterize the differences between patients who do better in one setting or the other? How can these characterizations assist in developing post-acute placement criteria and in characterizing the patient mix that should be used in defining an IRF pursuant to the 75% rule?

  5. What is the relative cost-effectiveness of IRF and SNF care for joint replacement patients?

    For which patients is it more cost-effective to be placed in an IRF and which patients in a SNF taking into account outcomes both at discharge and rehospitalizations during the first 3-6 months following discharge?

  6. Are comorbidities among joint replacement patients an adequate indicator of additional medical need during the rehabilitation process? Can a severity-of-illness measure serve as a better indicator of medical need? Are patients with greater medical needs served better in an IRF or a SNF?

    Do comorbidities or a severity of illness indicator have better predictive validity in terms of service utilization, costs, and outcomes?

  7. Can we design a more efficient course of rehabilitation interventions for joint replacement patients in IRFs and SNFs to reduce the length of stay and costs?

Tipo de estudo

Observacional

Inscrição (Real)

2384

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • District of Columbia
      • Washington, District of Columbia, Estados Unidos, 20010
        • National Rehabilitation Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

21 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Are 21 years of age or older,
  • Received a hip or knee replacement of any type for any reason, and
  • Admitted from any source.

To be included in the study's database, the above enrollment criteria need to be met. In addition, patients also must:

  • Have a minimum rehabilitation length of stay (LOS) of 3 days, and
  • Have complete admission and discharge FIM data.

Exclusion Criteria:

  • Joint replacements such as shoulder and ankle replacements since the rehabilitation for these patients is quite different. For most study patients, the joint replacement will be their first, but with the aging of the population, revisions are becoming more common. According to the MedPAC-RAND report, 4.8% of IRF and 6.3% of SNF joint replacement patients had a revision.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Colaboradores

Investigadores

  • Investigador principal: Gerben DeJong, PhD, NRH
  • Investigador principal: Susan Horn, PhD, ISIS/ICOR

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Links úteis

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de novembro de 2005

Conclusão do estudo (Real)

1 de fevereiro de 2007

Datas de inscrição no estudo

Enviado pela primeira vez

9 de julho de 2007

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de julho de 2007

Primeira postagem (Estimativa)

11 de julho de 2007

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

11 de julho de 2007

Última atualização enviada que atendeu aos critérios de controle de qualidade

9 de julho de 2007

Última verificação

1 de julho de 2007

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2005-271

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever